Clinical trials recruiting for HR+, HER2-, Advanced Breast Cancer
4
Recruiting trials
13
US states with sites
4
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AVZO-021 | 2 |
| Fulvestrant | 2 |
| Letrozole | 2 |
| AVZO-023 | 1 |
| Abemaciclib | 1 |
| Carboplatin | 1 |
| Chidamide | 1 |
| Endocrine therapy | 1 |
| Everolimus | 1 |
| Ovarian function suppression(OFS) | 1 |
| Palbociclib | 1 |
| Ribociclib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 3 |
| Texas | 3 |
| California | 2 |
| Connecticut | 2 |
| Florida | 2 |
| Massachusetts | 2 |
| New York | 2 |
| Tennessee | 2 |
| Virginia | 2 |
| Oklahoma | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
Top cities
Boston, Massachusetts 2Cleveland, Ohio 2Columbus, Ohio 2Fairfax, Virginia 2Los Angeles, California 2Nashville, Tennessee 2New Haven, Connecticut 2New York, New York 2San Antonio, Texas 2Sarasota, Florida 2
Self-screener
Recruiting trials
- A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
- Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
- ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
- Study of AVZO-021 in Patients With Advanced Solid Tumors
Related conditions
Trials recruiting for HR+, HER2-, Advanced Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239HR+/HER2- Breast Cancer 17TNBC - Triple-Negative Breast Cancer 35Targeted Therapy 8Primary Peritoneal Cancer 6Fallopian Tube Cancer 10Epithelial Ovarian Cancer 10Endometrial cancer 68CCNE1 Amplification 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HR+, HER2-, Advanced Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.